Tumours with BRAF-mutations were more often right-sided (91.2% versus 45.0%, p < 0.001), and more often poorly differentiated or undifferentiated (35.3% versus 8.4%, p < 0.001), as were MSI tumours (87.8% versus 43.5%, p < 0.001 and 39.0% versus 6.3%, p < 0.001). Here, BRAF is linked to neoplasm.